Direct comparison
Allocation Concealment vs Blinding
Allocation concealment hides the next assignment before it happens; blinding hides it afterward. Two distinct, often-conflated RCT safeguards — compared here.
Ask about Allocation Concealment vs Blinding
Answers are drawn from this comparison and the rest of the CASRAI corpus, with a link to every source.
Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this
How do Allocation Concealment, Blinding (Masking) compare side by side?
The table below compares Allocation Concealment, Blinding (Masking) across 9 procurement-relevant dimensions, from what it hides through can exist without the other?.
Side-by-side comparison
| Dimension | Allocation Concealment | Blinding (Masking) |
|---|---|---|
| What it hides | Which group the next enrolled participant will be assigned to | Which group a participant already assigned belongs to |
| When it operates | Before and at the moment of assignment | After assignment, for the duration of the trial (sometimes beyond) |
| Bias it protects against | Selection bias — the enroller steering participants toward an arm | Performance bias (differential care/behavior) and detection/ascertainment bias (differential outcome assessment) |
| Is it always achievable? | Yes — a logistics problem, solvable regardless of the intervention | No — often infeasible for surgery, physiotherapy, most behavioral/lifestyle interventions |
| Who is kept unaware | The person enrolling and assigning participants | Any combination of participants, clinicians, outcome assessors, analysts |
| Typical mechanisms | Central/telephone/web randomization, SNOSE (sequentially numbered opaque sealed envelopes), sequentially numbered coded containers, pharmacy-controlled randomization | Placebo/sham comparator, double-dummy design, identical coded drug packaging, independent blinded outcome assessment |
| CONSORT 2010 checklist item | Item 9 (alongside item 8, sequence generation) | Item 11 — a separate item entirely |
| Evidence when it fails | Inadequate/unclear concealment associated with larger, more variable effect estimates (Schulz & Grimes, Lancet 2002) | Lack of blinded outcome assessment: 36% exaggeration for binary outcomes, 68% for scale-measured outcomes, 27% for time-to-event outcomes (Hrobjartsson et al., BMJ 2012 / CMAJ 2013 / Int J Epidemiol 2014) |
| Can exist without the other? | Yes — an open-label trial can still have fully concealed allocation | Rare in the reverse direction — a foreseeable sequence undermines both at once |
Common questions
Common questions about Allocation Concealment vs Blinding (Masking)
Are allocation concealment and blinding the same thing?
+
No. Allocation concealment hides the upcoming assignment from whoever enrolls participants, before it happens, and protects against selection bias. Blinding hides an assignment that has already happened, from participants and/or study staff, and protects against performance and detection bias. They are separate CONSORT 2010 checklist items (9 and 11) and separate methodological safeguards, even though the terms are frequently used interchangeably in practice.
Can a trial have allocation concealment without blinding?
+
Yes, and this is common. An open-label (unblinded) randomized controlled trial — for example, a pragmatic trial comparing surgery to physiotherapy, where the intervention cannot be disguised — can still use central randomization or another concealment mechanism so the enrolling investigator never knows the next assignment in advance. Concealment and blinding are independent design choices; only concealment is available in every trial.
If a trial reports being "double-blind," does that mean allocation was concealed?
+
Not necessarily, and this is exactly the conflation that causes confusion. "Double-blind" describes who was kept unaware of the assignment after randomization; it says nothing about how (or whether) the assignment sequence was concealed from the enrolling investigator beforehand. A complete methods section reports both, separately, per CONSORT 2010 items 9 and 11.
Which failure is more consequential for a trial’s validity?
+
Both matter, but they are not interchangeable risks. A concealment failure introduces selection bias at the point of enrollment, which cannot be corrected after the fact by anything done later in the trial. A blinding failure introduces performance or detection bias during the trial, which can sometimes be partially mitigated — for example, by using a blinded outcome assessor even when participants and treating clinicians cannot be blinded.
